2022 M&A Healthcare Advisors Transactional Outlook Part Two: Pharmacy

Name: 2022 M&A Healthcare Advisors Transactional Outlook Part Two: Pharmacy
Uploaded: 2022-03-09T22:38:28.000Z
Description: M&A Healthcare Advisors has released the second video in its Transactional Outlook series. In the most recent video, company Partner & Executive Advisor Andre Ulloa focuses on four types of pharmacy. Ulloa provided the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy. “Specialty pharmacy valuations have remained stable in recent years…

M&A Healthcare Advisors has released the second video in its Transactional Outlook series. In the most recent video, company Partner & Executive Advisor Andre Ulloa focuses on four types of pharmacy. Ulloa provided the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy. “Specialty pharmacy valuations have remained stable in recent years…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

March 9, 2022, 10:38 PM UTC

M&A Healthcare Advisors has released the second video in its Transactional Outlook series. In the most recent video, company Partner & Executive Advisor Andre Ulloa focuses on four types of pharmacy.

Ulloa provided the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy.

“Specialty pharmacy valuations have remained stable in recent years in spite of downward pressure on sales, gross margin and net income,” Ulloa said.

While certain segments of the pharmacy market remain strong, not all of them have fared as well recently.

“Long-term care pharmacies have experienced one of the steepest valuation declines in recent years as a result of COVID and home-based care,” Ulloa noted.

For more insight into the healthcare business market, follow the latest from M&A Healthcare Advisors here.

Turn this into your own content

Create a free MarketScale workspace and publish your own experts. No credit card, no demo required.

Book a demo Start free

MarketScale platform

Want to launch your own podcast or show?

MarketScale gives B2B companies a full content studio: record, produce, and distribute your own channel. No agency, no crew, no guessing.

See how it works →

Keep exploring

Executive Thought Leadership
Put clinical leaders on the record.
State of GEO & AI Visibility
How B2B brands get cited by AI search.

healthcare Events

Future of Health Summit 2026

Jul 12, 2026 · Virtual

2026 HIMSS Global Health Conference & Exhibition

Aug 11, 2026 · Virtual

World Healthcare Congress 2026

Sep 14, 2026 · Virtual

See all healthcare events ›

Follow Healthcare Insights

Get new expert content in your inbox.

Become an Industry Voice

Share your expertise with 1,250+ B2B brands on MarketScale.

Apply to participate

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Run a free AI visibility check →Book a demo

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

Start free Book a demo

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace

One video edit a month, on us

AI writing, editing, and publishing tools

In-platform coaching to learn the system

More Healthcare Insights

Digital health enters a recalibration phase as ROI pressure reshapes procurement and AI workflows

Digital health is in a recalibration phase driven by increased pressure on ROI in procurement and AI workflows. A report by Holland & Knight highlights key trends in the healthcare sector, focusing on measurable outcomes and enhanced AI governance. The shift also emphasizes better management of chronic diseases.

01Digital health must demonstrate ROI due to increased pressure.
02Measurable outcomes and tighter AI governance are trending in healthcare.
03Chronic disease management is a critical focus area.

Jul 7, 2026

Digital health's July 2026 signal: AI wearables, a new CMS office, and the telehealth billing fight

In mid-2026, digital health is evolving with significant advancements such as AI-driven wearables and innovations in healthcare billing processes involving telehealth. A notable cardiac patch boasting 99.6% accuracy highlights progress in wearable technology. Meanwhile, the establishment of a new CMS AI office demonstrates the growing institutional interest in integrating AI into healthcare operations.

01AI wearables are being developed with high accuracy in health monitoring.
02The establishment of a CMS AI office indicates increased government focus on AI in healthcare.
03Debates over telehealth billing practices continue to shape the healthcare landscape.

Jul 5, 2026

OpenLoop acquires AI communication platform Hey Revia as digital health M&A heats up

OpenLoop has acquired AI communication platform Hey Revia as part of growing M&A activity in the digital health sector. The acquisition reflects an ongoing trend in digital health mergers and partnerships, including the announcement of FDA breakthrough status for Aurenar and Sharecare's collaboration with AWS. These developments highlight the increasing investment and strategic alliances shaping the digital health landscape.